Gonorrhea Test of Cure: When & Why It's Needed

A gonorrhea test of cure is a repeat NAAT done after treatment to confirm the infection is actually gone. The CDC recommends it only for throat (pharyngeal) gonorrhea, tested 7–14 days after treatment CDC STI Tx Guidelines. For genital and rectal infections, skip it and retest in about 3 months to catch reinfection.

Test of cure vs. retest for reinfection — they're not the same

This is the single most confused point, so let's settle it up front. A test of cure asks whether the treatment killed the bacteria that were there. A retest for reinfection asks whether you've picked up a new infection from an untreated or new partner. They happen at different times, for different reasons, and most people only need the second one.

For uncomplicated genital and rectal gonorrhea, the standard injection works reliably, so routine test of cure isn't advised. The throat is the exception, and it comes down to how this bacterium behaves. Gonorrhea is caused by Neisseria gonorrhoeae, which can colonize the genitals, rectum, and throat CDC, About Gonorrhea. The infection is curable, but no medicine reverses damage already done, so confirming clearance at the throat matters.

How a test of cure is done — the test and the sample

The same technology used to diagnose gonorrhea confirms cure: a nucleic acid amplification test (NAAT), which detects the bacterium's genetic material rather than trying to grow it. NAAT is the preferred screening method, with sensitivity usually above 90% and specificity around 99% CDC, panel physician instructions. That accuracy lets it double as the recheck tool.

The sample depends on where the infection lives. For the throat, that's a pharyngeal swab — a quick wipe at the back of the throat and tonsils. For other sites: first-catch urine for the genitals (men and women), a vaginal swab as an alternative for women, and a rectal swab for rectal infection. Patient-collected swabs are acceptable. Screen every anatomic site that was exposed; forget one and the infection gets missed. To see how each specimen and platform works, here's the full breakdown of the gonorrhea test and what the results mean.

One caveat on NAAT for test of cure: because it detects genetic material, not living bacteria, testing too soon can pick up residual fragments and produce a false-positive. The recommended window for a pharyngeal recheck is 7–14 days after treatment, long enough for dead organisms to clear.

Why the throat is the problem child

Pharyngeal gonorrhea is harder to cure than genital infection. Even when the bacteria are fully susceptible to the antibiotic, throat infections failed treatment with ceftriaxone about 4.6% of the time Clin Infect Dis, 2020. That's why a test of cure is built into throat care and nowhere else.

Two things make the throat dangerous. It's a resistance breeding ground, where gonorrhea can pick up resistance genes from the harmless Neisseria species that already live there. And throat infections are usually symptomless and can persist for up to 16 weeks, so an undetected case sits around quietly, swapping genes and spreading. Confirming cure closes that gap.

Why resistance makes confirmation matter more than ever

Treatment options have been narrowing for decades. Gonorrhea has progressively defeated sulfonamides, penicillin, tetracyclines, fluoroquinolones, and cefixime Treatment Failure review. Azithromycin was dropped from the regimen after isolates with elevated azithromycin MICs rose from 0.6% in 2013 to 4.6% in 2018, leaving a single ceftriaxone injection as the lone first-line treatment. Cephalosporins are now described as the last reliable class, and the ceftriaxone-resistant FC428 strain that emerged in Japan in 2015 has since spread internationally, though no verified US clinical ceftriaxone treatment failures have been reported to date. The WHO estimates 82 million new gonorrhea infections worldwide in 2020 WHO. In that environment, confirming that a hard-to-treat throat infection actually cleared is a form of surveillance. The CDC tracks resistance through GISP, eGISP, and SURRG (GISP and eGISP folded into CARGOS in August 2024) CDC, Drug-Resistant Gonorrhea.

Timing: when to test after treatment (and after exposure)

For a pharyngeal test of cure, the window is 7–14 days after treatment. Test before that and dead bacterial DNA can fool the NAAT; wait far longer and you blur the line between a treatment failure and a fresh reinfection.

Timing for the original diagnostic test is a separate question. There's no official CDC or USPSTF figure for how soon after exposure a NAAT turns positive, so don't anchor to a specific day count you saw elsewhere. For practical guidance on when to test after exposure and how the windows differ by infection, use that resource. Reinfection is common, often from a partner who was never treated, so plan to retest about 3 months after treatment regardless of whether you needed a test of cure.

Who should get screened

The USPSTF (2021, Grade B) recommends screening sexually active women, including pregnant people, who are 24 or younger, and those 25 and older at increased risk USPSTF, 2021. For men, the evidence was judged insufficient to recommend for or against routine screening (Grade I), which means population-wide screening lacks the evidence base, not that men shouldn't test. Anyone with new or multiple partners, a partner who tested positive, or symptoms should test, and men who have sex with men benefit from site-specific screening at the throat and rectum.

Where you live shapes your baseline risk more than most people expect. In 2023, reported gonorrhea ran about 180 per 100,000 nationally — roughly 601,000 cases, down from a 2021 peak of 214 per 100,000 — but ranged from that national figure up to 853 in Washington, DC, 311 in Alaska, and 288 in Louisiana CDC AtlasPlus, 2023. Local prevalence is part of why screening recommendations exist at all.

What getting tested is actually like, and what it costs

A typical visit is fast. You give a first-catch urine sample (the first part of your stream, ideally after not urinating for an hour or so), and if you've had oral or anal sex, you add a quick throat or rectal swab. Ask for every exposed site by name. Give only urine when your infection is in your throat and the throat infection gets missed, and that's the kind of case that needs a test of cure later.

Testing is free or low-cost at many public health clinics, and if you test positive the ceftriaxone injection is usually given on-site the same day. At-home kits let you collect samples privately and mail them in. For the full walkthrough of both routes, see how to get tested for gonorrhea at home or clinic. You can also get tested through an order online, or compare testing providers to find one that swabs all the sites you need.

Reading your test-of-cure results

A negative test of cure at the appropriate window means the treatment worked at that site and the infection cleared. A positive result a week or two after treatment is unusual and points to either a true treatment failure (rare, but the reason this check exists for the throat) or very early reinfection from continued exposure. A positive recheck is a reason to call your clinician rather than re-dose yourself, and treatment failures are reported to public health labs so resistance can be tracked.

If your test is positive

Gonorrhea is curable — a single ceftriaxone injection is the first-line regimen — but medicine can't undo damage that's already happened, so don't delay. For dosing details, partner treatment, and what recovery looks like, see the full treatment guidance, and review how is gonorrhea spread? transmission & risk so you can avoid passing it on or getting reinfected while you wait.

When to see a clinician

• You had a throat infection treated and need the recommended 7–14 day test of cure scheduled.
• Your symptoms haven't resolved after treatment, or they return.
• A test-of-cure or retest comes back positive after you completed treatment.
• A recent partner tested positive, or you've had a new partner since treatment.
• You're pregnant, since untreated gonorrhea can affect the pregnancy and newborn and screening recommendations specifically include pregnant people.